List view / Grid view
GSK has announced that the first batch of its candidate…
23 January 2015 | By GlaxoSmithKline
GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa...
GlaxoSmithKline announced the launch of Action Potential Venture Capital (APVC)…
8 August 2013 | By GlaxoSmithKline
GlaxoSmithKline announced the launch of Action Potential Venture Capital (APVC) Limited...
James Shannon has been named GSK’s Chief Medical Officer, effective…
4 May 2012 | By GlaxoSmithKline
James Shannon has been named GSK’s Chief Medical Officer, effective 1 May...
GlaxoSmithKline announced that topline results have been received...
16 November 2011 | By GlaxoSmithKline
GlaxoSmithKline announced that topline results have been received...
Jens Eckstein has been named President of SR One, GSK’s…
7 September 2011 | By GSK
Jens Eckstein has been named President of SR One, GSK’s independent healthcare venture organisation, effective 1 October...
The CHMP has issued a positive opinion, recommending marketing authorisation…
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...
GlaxoSmithKline and Theravance, Inc. announced today that GSK will increase…
29 November 2010 | By GlaxoSmithKline
GlaxoSmithKline and Theravance, Inc. announced today that GSK will increase its shareholding in Theravance through the purchase of Theravance common stock in a private placement...
